Atrial Natriuretic Factor (4-28) from multiple species is a shared peptide region used to investigate conserved ligand-binding determinants. Its structure supports studies of structural flexibility and motif placement. Researchers analyze its folding to evaluate comparative receptor affinity. The molecule enriches cross-species natriuretic peptide research.
CAT No: A17047
CAS No:95896-08-5
Synonyms/Alias:Atrial Natriuretic Factor (4-28) (human, bovine, porcine);Anaritida;95896-08-5;Anaritide;Anaritidum;Anaritidum [Latin];Anaritida [Spanish];Anaritide [INN:BAN];Atrial Natriuretic Factor (4-28) (human, bovine, porcine);UNII-1M00R25BPL;Wy 47,663;1M00R25BPL;DTXSID401336852;AT42476;FA108575;Atrial natriuretic factor(4-28)(human,bovine,porcine);Atriopeptin-21 (rat), N-L-arginyl-8-L-methionine-21a-L-phenylalanine-21b-L-arginine-21c-L-tyrosine-;
2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
3. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More